Year | Animal | AKI model | MSC source | Preconditioning | Outcomes | References |
---|---|---|---|---|---|---|
2012 | Rat | I/R | BM | Incubation with cytokines or chemical compounds | Increased SDF-1 level, migration, survival, secretory capacity | [10] |
2013 | Mice | Cisplatin | BM | Incubation with cytokines or chemical compounds | Increased CXCR4 expression, migration, survival, secretory capacity | [105] |
2014 | Rat | Gentamicin | BM | Co-injection | Increased CXCR4 and CXCR7 expression, migration, proliferative ability, secretory capacity | [108] |
2013 | Mice | I/R | BM | Co-injection | Increased SDF-1 level, migration | [109] |
2013 | Rat | I/R | BM | Hypoxia stimulation | Increased HIF-1α and CXCR4 expression, migration, retention time, secretory capacity | [114] |
2013 | Rat | I/R | BM | Genetic modification | Increased CXCR4 expression, migration, secretory capacity | [115] |